Chinese Journal of Tissue Engineering Research ›› 2012, Vol. 16 ›› Issue (3): 535-538.doi: 10.3969/j.issn.1673-8225.2012.03.035

Previous Articles     Next Articles

Different cardiovascular stent materials effects on endothelin and vascular restenosis in elderly patients with coronary artery disease

Liu Yan-ming1, Wang Xue-fang2   

  1. 1Department of Cardiology Ⅱ, the 251 Hospital of Chinese PLA, Zhangjiakou  075000, Hebei Province, China; 2School of Basic Medicine, Hebei North University, Zhangjiakou  075000, Hebei Province, China
  • Received:2011-07-13 Revised:2011-08-09 Online:2012-01-15 Published:2012-01-15
  • About author:Liu Yan-ming★, Master, Associate chief physician, Department of Cardiology Ⅱ, the 251 Hospital of Chinese PLA, Zhangjiakou 075000, Hebei Province, China wxfang_2003@ yahoo.com.cn

Abstract:

ACKGROUND: Stent implantation is an effective way to treat coronary heart disease.
OBJECTIVE: To study the effects of different cardiovascular stent materials on vascular restenosis and endothelin content in elderly patients with coronary heart disease.
METHODS: The first author searched VIP databases for articles published 1995-01/2011-06 using the keywords of cardiovascular stents, elderly coronary heart disease, endothelin, vascular restenosis”.
RESULTS AND CONCLUSION: Diffuse coronary vascular disease, vascular wall damage, thrombosis, inflammatory factors and cytokines are more seen in elderly patients than young and middle-aged patients receiving simple balloon angioplasty. Postoperative long- and middle-term vascular restenosis rate is also higher in young and middle-aged patients. Bare-metal stents can reduce the incidence of vascular restenosis and thrombosis and the production of various growth factors and cytokines as compared with simple balloon angioplasty. Drug stents are effective to inhibit vascular recoil and negative remodeling, reduce the incidence of long- and middle-term restenosis, decrease the occurrence of complications and improve the quality of life of elderly patients with coronary heart disease.

CLC Number: